What rates 10% for Prostate Cancer under 38 CFR § 4.115b, DC 7528?

Under 38 CFR § 4.115b, DC 7528 (DC 7528), a 10% rating for Prostate Cancer requires: Daytime voiding interval between two and three hours, or awakening to void two times per night; or mild renal dysfunction.

What secondary conditions are linked to Prostate Cancer?

Common secondary conditions for Prostate Cancer include Urinary Incontinence, Erectile Dysfunction, Bone Metastases, Major Depressive Disorder, Hormonal Dysfunction. Secondary service connection is established under 38 C.F.R. 3.310 when a condition is caused or aggravated by an already service-connected disability.

What happens during a C&P exam for Prostate Cancer?

Bring all relevant medical records and a written list of symptoms. Report your worst days, not your best. The VA rates based on overall impairment.

← All Condition Guides

CLAIM RECON INTEL

Prostate Cancer

Q: What are the VA rating percentages for Prostate Cancer?

Prostate Cancer (DC 7528) is rated at 100%, 10%, 20%, 40%, 60% under 38 CFR § 4.115b, DC 7528. DC 7528 verbatim NOTE — 100% during active malignancy (following surgical / X-ray / antineoplastic chemotherapy / or other therapeutic procedure). The 100% rating continues with a mandatory VA examination at the expiration of six months; any change in evaluation is subject to § 3.105(e). If no local recurrence or metastasis, rate-as residuals via voiding dysfunction OR renal dysfunction, whichever is predominant.

Q: What rates 100% for Prostate Cancer under 38 CFR § 4.115b, DC 7528?

Under 38 CFR § 4.115b, DC 7528 (DC 7528), a 100% rating for Prostate Cancer requires: DC 7528 verbatim NOTE — 100% during active malignancy (following surgical / X-ray / antineoplastic chemotherapy / or other therapeutic procedure). The 100% rating continues with a mandatory VA examination at the expiration of six months; any change in evaluation is subject to § 3.105(e). If no local recurrence or metastasis, rate-as residuals via voiding dysfunction OR renal dysfunction, whichever is predominant.

Q: What rates 20% for Prostate Cancer under 38 CFR § 4.115b, DC 7528?

Under 38 CFR § 4.115b, DC 7528 (DC 7528), a 20% rating for Prostate Cancer requires: Daytime voiding interval between one and two hours, or awakening to void three to four times per night; or requiring the wearing of absorbent materials which must be changed less than two times per day.

Q: What rates 40% for Prostate Cancer under 38 CFR § 4.115b, DC 7528?

Under 38 CFR § 4.115b, DC 7528 (DC 7528), a 40% rating for Prostate Cancer requires: Daytime voiding interval less than one hour, or awakening to void five or more times per night; or requiring the wearing of absorbent materials which must be changed two to four times per day.

Q: What rates 60% for Prostate Cancer under 38 CFR § 4.115b, DC 7528?

Under 38 CFR § 4.115b, DC 7528 (DC 7528), a 60% rating for Prostate Cancer requires: Requiring the use of an appliance or the wearing of absorbent materials which must be changed more than four times per day; or moderate to severe renal dysfunction.

Q: What evidence do I need for a Prostate Cancer VA claim?

Key evidence for a Prostate Cancer claim includes: Service treatment records; Current medical diagnosis and treatment records; Buddy/lay statements; Prescription history; Employment impact documentation. All evidence should document both the condition and its impact on daily functioning.

DC 752838 C.F.R. § 4.115b

Diagnostic Code

DC 7528

38 C.F.R. § 4.115b

Rating Range

10–100%

5 severity tiers

Source

Referenced

38 C.F.R. Part 4

Prostate Cancer is rated by the U.S. Department of Veterans Affairs under DC 7528 of 38 CFR § 4.115b, DC 7528 across 5 severity tiers (100% / 10% / 20% / 40% / 60%). Service connection requires (1) a current diagnosis, (2) an in-service event, injury, or exposure, and (3) a medical nexus opinion linking the two under 38 C.F.R. § 3.303. This condition is frequently rated as secondary to Urinary Incontinence or Erectile Dysfunction under 38 C.F.R. § 3.310.

Educational tool only. Not legal or medical advice. Not affiliated with the VA.

Overview

Malignant neoplasm of the prostate gland. One of the most commonly claimed VA cancers. Rated 100% during active disease. Presumptive for Agent Orange exposure. After treatment, rated on residuals.

Rating Criteria

100%

DC 7528 verbatim NOTE — 100% during active malignancy (following surgical / X-ray / antineoplastic chemotherapy / or other therapeutic procedure). The 100% rating continues with a mandatory VA examination at the expiration of six months; any change in evaluation is subject to § 3.105(e). If no local recurrence or metastasis, rate-as residuals via voiding dysfunction OR renal dysfunction, whichever is predominant.

10%

Daytime voiding interval between two and three hours, or awakening to void two times per night; or mild renal dysfunction.

20%

Daytime voiding interval between one and two hours, or awakening to void three to four times per night; or requiring the wearing of absorbent materials which must be changed less than two times per day.

40%

Daytime voiding interval less than one hour, or awakening to void five or more times per night; or requiring the wearing of absorbent materials which must be changed two to four times per day.

60%

Requiring the use of an appliance or the wearing of absorbent materials which must be changed more than four times per day; or moderate to severe renal dysfunction.

03Key Evidence

—Service treatment records

—Current medical diagnosis and treatment records

—Buddy/lay statements

—Prescription history

—Employment impact documentation

—Any relevant diagnostic testing

04C&P Exam Tips

1Bring all relevant medical records and a written list of symptoms.

2Report your worst days, not your best. The VA rates based on overall impairment.

3Document how the condition affects daily activities, work, and relationships.

4Mention all medications and their side effects.

5Bring buddy statements from people who observe your symptoms.

05Secondary Conditions

Urinary IncontinenceMODERATE

Erectile DysfunctionMODERATE

Surgery or radiation damages nerves

Bone MetastasesMODERATE

Prostate cancer commonly spreads to bone

Major Depressive DisorderMODERATE

Cancer diagnosis and treatment effects

Hormonal DysfunctionMODERATE

Androgen deprivation therapy effects

OsteoporosisMODERATE

Hormone therapy weakens bones

More in Genitourinary

Chronic Kidney Disease Kidney Stones Urinary Incontinence Urinary Frequency Prostate (BPH)Interstitial Cystitis Chronic UTI Testicular Conditions All conditions →

Tools

Rating Calculator →Secondaries Explorer →C&P Exam Prep →PACT Act Scanner →2026 Rates →

Sources & Editorial

Rating criteria reference 38 C.F.R. Part 4 (Schedule for Rating Disabilities). This entry has not yet undergone editorial review against the live regulation text — consult the authoritative source directly before relying on the criteria shown.

View 38 C.F.R. Part 4 on eCFR →Editorial Standards →Suggest a correction →

EDUCATIONAL TOOL ONLY. NOT LEGAL OR MEDICAL ADVICE.
NOT AFFILIATED WITH THE U.S. DEPARTMENT OF VETERANS AFFAIRS.
CLAIM RECON 2026

LOADING